reduc
morbid
mortal
integr
case
manag
pilot
studi
detect
respiratori
virus
patient
acut
lower
respiratori
infect
alri
design
part
nationwid
surveil
diseas
korea
studi
popul
consist
hospit
patient
age
year
bronchiol
pneumonia
croup
acut
respiratori
distress
syndrom
prospect
studi
perform
two
hundr
ninetyseven
nasopharyng
secret
collect
multiplex
revers
transcriptas
polymeras
chain
reaction
rtpcr
polymeras
chain
reaction
pcr
perform
detect
respiratori
virus
posit
rtpcrpcr
result
viral
cultur
proceed
confirm
respiratori
virus
identifi
patient
detect
rate
follow
respiratori
syncyti
viru
rsv
commonli
detect
human
metapneumoviru
hmpv
human
corona
viru
hcov
adenoviru
human
bocaviru
hbov
parainfluenza
viru
piv
moviru
hmpv
human
bocaviru
hbov
human
corona
virus
hcov
oc
scan
multiplex
revers
transcriptas
polymeras
chain
reaction
rtpcr
polymeras
chain
reaction
pcr
eur
j
clin
microbiol
infect
di
rhinoviru
rv
influenza
viru
patient
alri
consist
rate
posit
result
rtpcr
viral
cultur
use
method
detect
viral
caus
seem
accept
nation
surveil
sever
acut
respiratori
infect
infant
children
acut
lower
respiratori
infect
alri
major
impact
health
servic
account
visit
children
health
facil
mani
emerg
viral
infect
caus
alri
may
detect
middl
outbreak
spring
throughout
almost
everi
tertiari
hospit
south
korea
certain
patient
admit
month
due
fatal
respiratori
infect
pediatrician
could
determin
causal
viru
outbreak
rapidli
progress
interstiti
pneumonia
subsequ
pneumothorax
prolong
ventil
care
diagnosi
acut
respiratori
distress
syndrom
ard
multipl
organ
failur
typic
diseas
progress
earli
molecular
viral
studi
possibl
patient
could
first
key
detect
causal
virus
nationwid
surveil
system
control
spread
infect
design
korea
center
diseas
control
prevent
kcdc
pilot
studi
conduct
establish
nationwid
surveil
system
alri
infant
children
year
age
south
korea
includ
classic
respiratori
virus
respiratori
syncyti
viru
rsv
parainfluenza
viru
piv
influenza
viru
adenoviru
rhinoviru
rv
recent
discov
virus
eg
human
metapneumethod
detect
causal
respiratori
virus
molecular
tool
known
sensit
present
studi
feasibl
establish
hospitalbas
respiratori
viral
surveil
system
prompt
report
system
tertiari
hospit
kcdc
investig
alri
patient
year
age
admit
sever
children
hospit
one
largest
tertiari
hospit
south
korea
examin
prospect
novemb
april
month
case
definit
moder
sever
lower
respiratori
infect
determin
accord
world
health
organ
recommend
surveil
standard
edit
part
diagnosi
pneumonia
croup
bronchiol
ard
includ
diagnos
physician
physic
examin
chest
xray
sampl
collect
nasopharyng
aspir
viral
transport
media
prospect
inform
consent
obtain
studi
approv
institut
review
board
sever
hospit
questionnair
ask
onset
manifest
symptom
admiss
durat
stay
sampl
collect
risk
factor
eg
parent
smoke
prematur
formula
feed
gastroesophag
reflux
neurolog
deficit
cardiovascular
defect
initi
diagnosi
radiograph
find
blood
test
treatment
inform
provid
pediatrician
enter
access
databas
microsoft
person
blind
viral
result
immunocompromis
patient
patient
receiv
chemotherapi
due
variou
cancer
take
immunosuppress
patient
admit
neonat
intens
care
unit
patient
sever
complex
heart
diseas
exclud
analys
perform
graphpad
prism
version
window
graphpad
softwar
inc
san
diego
ca
usa
pvalu
consid
signific
viral
dna
rna
extract
qiaamp
viral
mini
kit
qiagen
hilden
germani
onestep
multiplex
pcrrtpcr
reagent
rv
detect
kit
cosmo
genetech
seoul
south
korea
develop
kcdc
influenza
respiratori
viru
team
cosmo
genetech
use
sampl
show
posit
result
adenoviru
influenza
viru
piv
rsv
multiplex
pcr
method
underw
viral
cultur
readycel
diagnost
hybrid
athen
us
among
total
patient
sampl
collect
sampl
sampl
posit
total
virus
detect
studi
rsv
commonli
detect
hmpv
adenoviru
hbov
hcov
rv
piv
influenza
viru
patient
alri
coinfect
rate
detect
frequenc
viru
alri
respect
demograph
featur
clinic
manifest
depict
tabl
elaps
period
initi
present
symptom
time
sampl
significantli
differ
virusposit
sampl
virusneg
sampl
data
shown
howev
among
detect
virus
signific
differ
elaps
sampl
note
oneway
analysi
varianc
anova
sampl
time
promin
differ
adenoviru
hmpv
p
signific
differ
rsv
hmpv
hbo
hmpv
fig
cours
studi
rsv
outbreak
observ
novemb
decemb
rsv
detect
case
enrol
period
signific
differ
clinic
outcom
length
hospit
stay
indic
respiratori
difficulti
oxygen
therapi
among
group
rsv
infect
case
rsvhmpv
coinfect
case
hmpv
infect
case
pneumonia
diagnos
bronchiol
croup
ard
patient
among
patient
need
oxygen
therapi
treat
ventil
ard
patient
n
two
case
reveal
causal
virus
adenoviru
rsv
two
case
result
mortal
spite
meticul
treatment
total
parent
respond
questionnair
patient
breastf
month
age
patient
less
month
old
group
breastfeed
affect
rate
viru
detect
among
formulaf
infant
differ
term
viral
detect
older
month
younger
month
group
parent
smoke
respiratori
difficulti
index
item
nasal
flare
tachypnea
rr
chest
wall
retract
significantli
higher
smoke
group
determin
logist
regress
analysi
cofactor
rsv
infect
asthma
alri
patient
histori
prematur
gestat
age
week
found
patient
median
age
month
one
patient
receiv
rsv
monoclon
antibodi
group
virusposit
patient
rsv
except
one
case
posit
sampl
singl
viru
detect
multiplex
rtpcrpcr
put
viral
cultur
rsv
adenoviru
piv
influenza
b
isol
use
method
viral
cultur
perform
sampl
consist
result
rtpcrpcr
produc
sampl
agreement
rate
use
viral
nucleic
acid
multipl
method
high
sensit
physician
manag
alri
prolong
fever
administ
support
care
instead
switch
anoth
type
antibiot
diagnost
method
adopt
accur
diagnosi
although
costeffect
still
establish
howev
inappropri
prescrib
antibiot
viral
respiratori
infect
would
resolv
rigor
diagnosi
present
studi
amoxicillin
clavulan
frequent
prescrib
treatment
pneumonia
case
adenoviru
influenza
viral
infect
prolong
fever
strike
featur
could
wait
without
ad
antibiot
base
viral
laboratori
data
coher
featur
chest
radiograph
question
remain
whether
multiplex
pcrrtpcr
method
exclus
suitabl
respiratori
surveil
network
method
immunochromatographi
direct
fluoresc
antibodi
dfa
stain
enzym
immunoassay
produc
compat
result
molecular
studi
rsv
influenza
viru
piv
hmpv
suitabl
commerci
rapid
kit
could
use
first
mass
screen
neg
sampl
adopt
reflex
pcr
method
could
consid
rapid
cultur
kit
also
enabl
physician
make
time
diagnosi
convent
viral
infect
adenoviru
influenza
virus
isol
well
rapid
shell
viral
cultur
rtpcrpcr
method
studi
agreement
obtain
pcr
rapid
shell
viral
cultur
anoth
studi
similar
popul
concord
report
howev
recent
identifi
virus
hbov
hmpv
rv
hcov
known
hardli
cultur
virus
well
detect
multiplex
pcr
rtpcr
method
mass
screen
respiratori
virus
includ
unknown
virus
sever
respiratori
infect
would
accur
desir
viral
nucleic
acid
extract
sampl
subsequ
identif
primer
one
viral
gene
target
true
posit
sampl
could
miss
method
studi
two
kind
primer
includ
multiplex
rtpcr
kit
hmpv
hcov
influenza
viru
b
hospitalbas
surveil
sever
respiratori
infect
signific
merit
transmiss
sar
toronto
outbreak
nosocomi
case
rapid
viral
diagnosi
perform
hospit
would
help
prevent
nosocomi
infect
immunocompromis
patient
target
manag
addit
strict
diagnosi
affect
treatment
polici
directli
govern
support
total
cost
molecular
viral
diagnosi
tertiari
hospit
nation
surveil
earli
standard
broad
respira
fig
elaps
time
differ
initi
symptom
present
nasopharyng
sampl
virus
bar
repres
mean
valu
confid
interv
tori
sampl
would
possibl
regardless
insur
situat
patient
econom
state
thu
hospitalbas
surveil
network
superior
sentinel
surveil
system
aspect
appropri
sampl
time
elaps
period
sampl
examin
feedback
effect
viral
studi
conclus
pilot
studi
show
respiratori
viral
detect
use
multiplex
rtpcrpcr
feasibl
great
benefit
limit
establish
nation
hospitalbas
surveil
system
sever
lower
respiratori
infect
enabl
clinician
anticip
clinic
cours
help
use
minim
administr
antibiot
govern
rigor
viral
studi
might
viabl
solut
reduc
high
resist
total
medic
cost
antibiot
sever
respiratori
infect
